Tharimmune
Yahoo Finance • 3 months ago
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
RED BANK, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tharimmune, Inc. (Nasdaq: THAR), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and critical unmet medical... Full story
Yahoo Finance • 3 months ago
Tharimmune (THUR) Tumbles 20.7% on $5-Million Share Sale
We recently published 10 Stocks Losing Big. Tharimmune, Inc. (NASDAQ:THAR) is one of the worst performers of Tuesday. Tharimmune tumbled by 20.75 percent on Tuesday to close at $6.11 apiece as investor sentiment was dampened by a share sa... Full story
Yahoo Finance • 3 months ago
Unusual volume stocks in Thursday's session
Unusual volume stocks are being observed in Thursday's session. [unusualvolume] TOP UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT THAR [https://www.chartmill.com/stock/quote/THAR/profile] 32.17% THARIMMUNE INC (NASDAQ:THAR... Full story
Yahoo Finance • 3 months ago
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change OceanPal Inc. 95,039,961 0.1001 0.0929 0.0942 +0.0058 Opendoor Technolog... Full story
Yahoo Finance • 4 months ago
Tharimmune prices $1.74 million direct offering
* Tharimmune (NASDAQ:THAR [https://seekingalpha.com/symbol/THAR]) priced [https://seekingalpha.com/pr/20176093-tharimmune-announces-pricing-of-1_74-million-registered-direct-public-offering-of-common] a $1.74 million registered direct... Full story
Yahoo Finance • 5 months ago
Tharimmune executive chairman buys $500,000 in shares
Gravitas Capital LP, Executive Chairman at Tharimmune, Inc. (NASDAQ:THAR), has recently purchased 337,838 shares of common stock at a price of $1.48, according to a Form 4 filing with the Securities and Exchange Commission. The transaction... Full story
Yahoo Finance • 5 months ago
Tharimmune director Parikh buys $1,450 in company stock
Director Sanam Parikh of Tharimmune, Inc. (NASDAQ:THAR), a micro-cap biotech company with a market capitalization of $3.57 million, recently purchased 1,000 shares of the company’s common stock. According to a Form 4 filing with the Securi... Full story
Yahoo Finance • 5 months ago
Tharimmune CEO Appajosyula buys shares worth $90,972
Tharimmune, Inc. (NASDAQ:THAR) Chief Executive Officer Sireesh Appajosyula reported purchasing shares of the company’s common stock on June 20, 2025. The transactions involved the acquisition of 61,496 shares at prices ranging from $1.42 t... Full story
